Melatonin Mediates Osteoblast Proliferation Through the STIM1/ORAI1 Pathway

Area of Science:

• Endocrinology
• Bone Biology
• Cellular Calcium Signaling

Background:

• Osteoporosis (OP) is a major health issue for postmenopausal women.
• Melatonin, a pineal gland hormone, influences bone metabolism.
• Existing research suggests a link between melatonin and bone density.

Purpose of the Study:

• Investigate the correlation between serum melatonin levels and bone density in postmenopausal women.
• Evaluate the efficacy of melatonin supplementation in preventing and treating postmenopausal osteoporosis.
• Elucidate the cellular mechanisms underlying melatonin's effects on osteoblasts.

Main Methods:

• Serum melatonin levels measured by liquid chromatography-tandem mass spectrometry.
• Bone density and micro-architecture assessed using micro-CT in an animal model.
• Intracellular calcium concentrations and STIM1/ORAI1 pathway activation analyzed via fluorescence microscopy, plate reader, PCR, and Western Blot.

Main Results:

• A positive correlation was confirmed between blood melatonin levels and bone mineral density.
• Melatonin supplementation effectively reversed osteoporosis in a mouse model.
• Melatonin was shown to increase intracellular calcium via the STIM1/ORAI1 pathway, promoting osteoblast proliferation.

Conclusions:

• Melatonin shows promise as a therapeutic agent for postmenopausal osteoporosis.
• The STIM1/ORAI1 pathway is a key mediator of melatonin's bone-protective effects.
• This study provides a foundation for clinical applications of melatonin in osteoporosis management.